[1]Galactophore Department, First Peoples' Hospital of Kunming City, Yunnan Province, China.
Objective: To investigate the medical expenditure on HBVrelated diseases states and to identify the effect of health insurance on catastrophic health expenditure in Yunnan province of China Introduction: In China, HBV infection is the most common cause of chronic liver disease. More than half a million Chinese people would die annually from end-stage complications in association with huge healthcare costs and socioeconomic burden. Methods: A cross-sectional study was conducted to estimate the annual total direct costs and catastrophic health expenditure among patients with HBV and liver disease states. Patients' information was consecutively recorded at one of level three of first-class hospital in December 2012 to June 2013 in Yunnan, China. The total direct costs for four disease states were estimated by questionnaires. The hospital charge, outpatient fees, and the hospitalization fees being reimbursed and household catastrophic expenditure were identified. Results: The annual direct costs for each disease states were 19,496 Renminbi (RMB) Yuan in HBV without complication, 28,466 RMB Yuan in compensated cirrhosis, 46,061 RMB Yuan in decompensated cirrhosis, and 33,044 RMB Yuan in hepatocellular carcinoma (HCC) patients, respectively. The catastrophic expenditure occurred at each disease states. Health insurance reimbursement released financial burden incurred by medical expense of patients under high level of household economic status. Public health insurance regimes had helped the patients in different extent. Conclusions: Among patients with hepatitis B infection, the direct costs represent a significant economic burden. Health expenditure and financing systems must be considered to prevent the increase of household catastrophe, particular among the poor.
(8.0+极速模式)